These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 30089030)

  • 1. Regulation of the renal NaCl cotransporter by the WNK/SPAK pathway: lessons learned from genetically altered animals.
    Ostrosky-Frid M; Castañeda-Bueno M; Gamba G
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F146-F158. PubMed ID: 30089030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of KLHL3 and dietary K
    Ostrosky-Frid M; Chávez-Canales M; Zhang J; Andrukhova O; Argaiz ER; Lerdo-de-Tejada F; Murillo-de-Ozores A; Sanchez-Navarro A; Rojas-Vega L; Bobadilla NA; Vazquez N; Castañeda-Bueno M; Alessi DR; Gamba G
    Am J Physiol Renal Physiol; 2021 May; 320(5):F734-F747. PubMed ID: 33682442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distal convoluted tubule-specific disruption of the COP9 signalosome but not its regulatory target cullin 3 causes tubular injury.
    Maeoka Y; Bradford T; Su XT; Sharma A; Yang CL; Ellison DH; McCormick JA; Cornelius RJ
    Am J Physiol Renal Physiol; 2024 Oct; 327(4):F667-F682. PubMed ID: 39205661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased KLHL3 expression is involved in the activation of WNK-OSR1/SPAK-NCC cascade in type 1 diabetic mice.
    Guo Q; Zhang Y; Jiang GR; Zhang C
    Pflugers Arch; 2021 Feb; 473(2):185-196. PubMed ID: 33432425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
    Glover M; O'Shaughnessy KM
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.
    Argaiz ER; Chavez-Canales M; Ostrosky-Frid M; Rodríguez-Gama A; Vázquez N; Gonzalez-Rodriguez X; Garcia-Valdes J; Hadchouel J; Ellison D; Gamba G
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F734-F745. PubMed ID: 29846116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.
    Brown A; Meor Azlan NF; Wu Z; Zhang J
    Acta Pharmacol Sin; 2021 Apr; 42(4):508-517. PubMed ID: 32724175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
    Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium depletion stimulates Na-Cl cotransporter
    Ishizawa K; Xu N; Loffing J; Lifton RP; Fujita T; Uchida S; Shibata S
    Biochem Biophys Res Commun; 2016 Nov; 480(4):745-751. PubMed ID: 27942049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.
    Maeoka Y; Ferdaus MZ; Cornelius RJ; Sharma A; Su XT; Miller LN; Robertson JA; Gurley SB; Yang CL; Ellison DH; McCormick JA
    J Am Soc Nephrol; 2022 Mar; 33(3):584-600. PubMed ID: 35064051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
    Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
    PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutively Active SPAK Causes Hyperkalemia by Activating NCC and Remodeling Distal Tubules.
    Grimm PR; Coleman R; Delpire E; Welling PA
    J Am Soc Nephrol; 2017 Sep; 28(9):2597-2606. PubMed ID: 28442491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway.
    Wu A; Wolley M; Stowasser M
    J Hum Hypertens; 2019 Jul; 33(7):508-523. PubMed ID: 30723251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
    Sohara E; Uchida S
    Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation affecting the conserved acidic WNK1 motif causes inherited hyperkalemic hyperchloremic acidosis.
    Louis-Dit-Picard H; Kouranti I; Rafael C; Loisel-Ferreira I; Chavez-Canales M; Abdel-Khalek W; Argaiz ER; Baron S; Vacle S; Migeon T; Coleman R; Do Cruzeiro M; Hureaux M; Thurairajasingam N; Decramer S; Girerd X; O'Shaugnessy K; Mulatero P; Roussey G; Tack I; Unwin R; Vargas-Poussou R; Staub O; Grimm R; Welling PA; Gamba G; Clauser E; Hadchouel J; Jeunemaitre X
    J Clin Invest; 2020 Dec; 130(12):6379-6394. PubMed ID: 32790646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of with-no-lysine kinase signaling by Kelch-like proteins.
    Uchida S; Sohara E; Rai T; Sasaki S
    Biol Cell; 2014 Feb; 106(2):45-56. PubMed ID: 24313290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal COP9 Signalosome Deficiency Alters CUL3-KLHL3-WNK Signaling Pathway.
    Cornelius RJ; Si J; Cuevas CA; Nelson JW; Gratreak BDK; Pardi R; Yang CL; Ellison DH
    J Am Soc Nephrol; 2018 Nov; 29(11):2627-2640. PubMed ID: 30301860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular K
    Penton D; Czogalla J; Wengi A; Himmerkus N; Loffing-Cueni D; Carrel M; Rajaram RD; Staub O; Bleich M; Schweda F; Loffing J
    J Physiol; 2016 Nov; 594(21):6319-6331. PubMed ID: 27457700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.